GLAM - ETF AI Analysis
Top Page
Corgi Beauty, Skincare & Aesthetics ETF (GLAM)
Rating:61Neutral
Price Target:―
Positive Factors
Recent Short-Term Momentum
The ETF has shown strong one-month performance, suggesting recent positive momentum in its niche beauty and skincare theme.
Supportive Consumer and Healthcare Mix
Heavy exposure to health care and consumer defensive companies provides a base of businesses that tend to be more resilient across different economic conditions.
Several Strong-Performing Holdings
Some of the top positions, such as Colgate-Palmolive, International Flavors & Fragrances, Align Tech, and Establishment Labs, have delivered strong year-to-date gains that help support the fund’s overall results.
Negative Factors
High Stock and Sector Concentration
A small group of holdings and a heavy tilt toward health care and consumer sectors means the fund is less diversified and more exposed to setbacks in these areas.
Notable Lagging Top Holdings
Several major positions, including Ulta Beauty, Estée Lauder, Hims & Hers Health, AbbVie, and AptarGroup, have shown weak year-to-date performance, which can drag on the ETF’s returns.
Small Asset Base
With relatively low assets under management, the fund may face higher trading spreads and a greater risk of closure compared with larger, more established ETFs.
GLAM vs. SPDR S&P 500 ETF (SPY)
AUM978.37K
RegionGlobal
Expense Ratio0.35%
Beta0.39
IssuerCorgi
Inception DateMay 06, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume389
30 Day Avg. Volume1,899
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.96Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering25
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GLAM Summary
GLAM is the Corgi Beauty, Skincare & Aesthetics ETF, an actively managed fund focused on the global beauty and personal care theme rather than a traditional market index. It invests in companies tied to cosmetics, skincare, fragrances, beauty devices, and medical aesthetics. Well-known holdings include Colgate-Palmolive and The Estée Lauder Companies. Someone might invest in GLAM to tap into long-term growth trends in beauty and personal care while adding a focused theme to a broader portfolio. A key risk is that it is concentrated in one sector, so its price can swing more than a diversified market fund.
How much will it cost me?This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s higher than the cost of a typical broad, passively managed index ETF because this is an actively managed, specialized fund focused on the beauty and personal care sector.
What would affect this ETF?This ETF could benefit if global consumer spending on beauty and personal care keeps growing, especially as aging populations, higher incomes, and online shopping support demand for brands like Colgate-Palmolive, Estée Lauder, and Ulta Beauty, while medical-aesthetics names such as AbbVie and Align gain from increased interest in cosmetic treatments. On the downside, it is heavily focused on health care and consumer staples, so tighter health regulations, changes in drug or cosmetic approvals, weaker consumer confidence, or higher interest rates that hurt growth stocks and global markets could weigh on its performance.
GLAM Top 10 Holdings
GLAM leans heavily on health care and consumer staples, with AbbVie and Hims & Hers Health acting as the main growth engines thanks to their rising share prices and upbeat outlooks. Classic household names like Colgate-Palmolive and Kenvue provide a steadier backbone, helping smooth out volatility. On the flip side, Estée Lauder and Ulta Beauty have been lagging, tugging at overall returns as they work through business challenges. With a global mix of beauty, skincare, and aesthetics players, the fund is clearly concentrated in the personal care theme rather than any single country.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AbbVie | 14.44% | $142.35K | $443.36B | 28.54% | 66 Neutral | |
| Colgate-Palmolive | 7.74% | $76.30K | $73.06B | 9.33% | 63 Neutral | |
| International Flavors & Fragrances | 5.14% | $50.63K | $20.23B | 14.02% | 61 Neutral | |
| Kenvue, Inc. | 5.07% | $50.01K | $36.94B | -10.88% | 73 Outperform | |
| The Estée Lauder Companies | 5.00% | $49.32K | $30.35B | -7.84% | 56 Neutral | |
| Ulta Beauty | 4.98% | $49.09K | $22.05B | 3.77% | 78 Outperform | |
| ― | 4.68% | $46.18K | ― | ― | ― | |
| AptarGroup | 4.47% | $44.04K | $8.55B | -3.72% | 60 Neutral | |
| e.l.f. Beauty | 4.21% | $41.46K | $4.89B | -28.93% | 68 Neutral | |
| Align Tech | 4.19% | $41.27K | $12.11B | 22.78% | 74 Outperform |
GLAM Technical Analysis
Positive
―
Price Trends
26.89
Positive
Market Momentum
0.36
Positive
58.16
Neutral
42.82
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GLAM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.04, equal to the 50-day MA of 26.89, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.36 indicates Positive momentum. The RSI at 58.16 is Neutral, neither overbought nor oversold. The STOCH value of 42.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GLAM.
GLAM Peer Comparison
Comparison Results
Performance Comparison
GLAM
Corgi Beauty, Skincare & Aesthetics ETF
28.36
2.82
11.04%
FFND
Future Fund Active ETF
―
―
―
CSNR
Cohen & Steers Natural Resources Active ETF
―
―
―
FDCF
Fidelity Disruptive Communications ETF
―
―
―
HECO
SPDR Galaxy Hedged Digital Asset Ecosystem ETF
―
―
―
BREW
Corgi Coffee & Energy Drinks ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents